glp-1 receptor agonists cardiovascular benefits Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review A Comprehensive Review of the

Despite variations in data sources, adjustment techniques, risk estimates, and comparator drugs, these findings collectively suggest that GLP-1RAs are not associated with an altered risk of depression

It is the most common cause of preventable blindness in the United States

Head-to-head efficacy comparison Retatrutide versus semaglutide is not even close in terms of raw weight loss numbers

If you need emergency surgery (with no time to prepare), your surgical risk will be elevated simply based on the fact that you are taking a GLP-1 drug

Unlike treatment with GLP-1RAs, which generally leads to body weight and fat mass reduction, pioglitazone dose-dependently increases body weight and fat mass